| Literature DB >> 30917031 |
Theodor Borgovan1, Lorin Crawford2, Chibuikem Nwizu1, Peter Quesenberry1.
Abstract
Many different subpopulations of subcellular extracellular vesicles (EVs) have been described. EVs are released from all cell types and have been shown to regulate normal physiological homeostasis, as well as pathological states by influencing cell proliferation, differentiation, organ homing, injury and recovery, as well as disease progression. In this review, we focus on the bidirectional actions of vesicles from normal and diseased cells on normal or leukemic target cells; and on the leukemic microenvironment as a whole. EVs from human bone marrow mesenchymal stem cells (MSC) can have a healing effect, reversing the malignant phenotype in prostate and colorectal cancer, as well as mitigating radiation damage to marrow. The role of EVs in leukemia and their bimodal cross talk with the encompassing microenvironment remains to be fully characterized. This may provide insight for clinical advances via the application of EVs as potential therapy and the employment of statistical and machine learning models to capture the pleiotropic effects EVs endow to a dynamic microenvironment, possibly allowing for precise therapeutic intervention.Entities:
Keywords: biomarkers; extracellular vesicles; leukemia; machine learning; stem cells
Year: 2019 PMID: 30917031 DOI: 10.1152/ajpcell.00017.2019
Source DB: PubMed Journal: Am J Physiol Cell Physiol ISSN: 0363-6143 Impact factor: 4.249